ResearcherFirst Affiliated Hospital of Dalian Medical UniversityNo recent work listed
Chenqi Wang
Matched on ORCID iD 0000-0001-6907-5025; OpenAlex author ID A5068547155. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 3
- Correlation between Macrophage Polarization and PD-L1-Related Tumor Microenvironmental Alteration and Metastasis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2023/7971306↗
- Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go? Co-author DOI 10.3389/fonc.2022.828223↗
- Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A meta-analysis. Co-author DOI 10.1097/md.0000000000026342↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dan Chen · 3 shared papers, 2021–2023 · strength 0.41
- Paper Correlation between Macrophage Polarization and PD-L1-Related Tumor Microenvironmental Alteration and Metastasis in Pan… DOI 10.1155/2023/7971306↗
- Paper Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go? DOI 10.3389/fonc.2022.828223↗
- Paper Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A… DOI 10.1097/md.0000000000026342↗
- Jiangning Gu · 3 shared papers, 2021–2023 · strength 0.41
- Paper Correlation between Macrophage Polarization and PD-L1-Related Tumor Microenvironmental Alteration and Metastasis in Pan… DOI 10.1155/2023/7971306↗
- Paper Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go? DOI 10.3389/fonc.2022.828223↗
- Paper Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A… DOI 10.1097/md.0000000000026342↗
- Haifeng Luo · 3 shared papers, 2021–2023 · strength 0.41
- Paper Correlation between Macrophage Polarization and PD-L1-Related Tumor Microenvironmental Alteration and Metastasis in Pan… DOI 10.1155/2023/7971306↗
- Paper Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go? DOI 10.3389/fonc.2022.828223↗
- Paper Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A… DOI 10.1097/md.0000000000026342↗
- Guang Tan · 2 shared papers, 2022–2023 · strength 0.29
- Yunlong Chen · 2 shared papers, 2021–2022 · strength 0.25
- Xiang 'Anthony' Chen · 2 shared papers, 2021–2022 · strength 0.25
- Lili Yang · 1 shared paper, 2022 · strength 0.13
- Jian Du · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.